Tumor necrosis factor alpha-308 and Lymphotoxin alpha+252 genetic polymorphisms and the susceptibility to non-Hodgkin lymphoma in Egypt

Leukemia Research

Volumn 36, Issue 6, 2012, Pages 694-698

  Ibrahim, Azza ^a   Rahman, Hala Abdel ^a   Khorshied, Mervat ^a   Sami, Rania ^a   Nasr, Nelly ^a   Khorshid, Ola ^b  

^a CAIRO UNIVERSITY   (Egypt)

^b CAIRO UNIVERSITY   (Egypt)

Author keywords

Egypt; Lymphotoxin alpha (LT ); NHL; PCR RFLP; Tumor necrosis factor alpha (TNF )

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; CANCER RISK; CONTROLLED STUDY; EGYPT; FEMALE; GENE; GENETIC SUSCEPTIBILITY; GENOTYPE; HAPLOTYPE; HUMAN; LYMPHOTOXIN ALPHA GENE; MAJOR CLINICAL STUDY; MALE; NONHODGKIN LYMPHOMA; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SINGLE NUCLEOTIDE POLYMORPHISM; TUMOR NECROSIS FACTOR ALPHA GENE;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CASE-CONTROL STUDIES; EGYPT; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; HAPLOTYPES; HUMANS; LYMPHOMA, NON-HODGKIN; LYMPHOTOXIN-ALPHA; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC; PROMOTER REGIONS, GENETIC; TUMOR NECROSIS FACTOR-ALPHA; YOUNG ADULT;

EID: 84859851311     PISSN: 01452126     EISSN: 18735835     Source Type: Journal    
DOI: 10.1016/j.leukres.2011.11.016     Document Type: Article

References (19)

1. Morton L.M., Purdue M.P., Zheng T., Wang S.S., Armstrong B., Zhang Y., et al. Risk of non-Hodgkin lymphoma associated with germline variation in genes that regulate the cell cycle, apoptosis, and lymphocyte development. Cancer Epidemiol Biomarkers Prev 2009, 18(4):1259-1270.
2. Skibola C.F., Curry J.D., Nieters A. Genetic susceptibility to lymphoma. Haematologica 2007, 92:960-969.
3. Goldman L., Ezzat S., Mokhtar N., Abdel-Hamid A., Fowler N., Gouda I., et al. Viral and non-viral risk factors for non-Hodgkin's lymphoma in Egypt: heterogeneity by histological and immunological subtypes. Cancer Causes Control 2009, 20(6):981-987.
4. Kádár K., Kovács M., Karádi I., Melegh B., Pocsai Z., Mikala G., et al. Polymorphisms of TNF-alpha and LT-alpha genes in multiple myeloma. Leuk Res 2008, 32(10):1499-1504.
5. Purdue M.P., Lan Q., Kricker A., Grulich A.E., Vajdic C.M., Turner J., et al. Polymorphisms in immune function genes and risk of non-Hodgkin lymphoma: findings from the New South Wales non-Hodgkin lymphoma study. Carcinogenesis 2007, 28:704-712.
6. Wang S.S., Purdue M.P., Cerhan J.R., Zheng T., Menashe I., Armstrong B.K., et al. Common gene variants in the tumor necrosis factor (TNF) and TNF receptor superfamilies and NF-κB transcription factors and non-Hodgkin lymphoma risk. PLoS One 2009, 4(4):e5360.
7. Rothman N., Skibola C.F., Wang S.S., Morgan G., Lan Q., Smith M.T., et al. Genetic variation in TNF and IL10 and risk of non-Hodgkin lymphoma: a report from the Inter-Lymph Consortium. Lancet Oncol 2006, 7:27-38.
8. Elahi M.M., Asotra K., Matata B.M., Mastana S.S. Tumor necrosis factor alpha-308 gene locus promoter polymorphism: an analysis of association with health and disease. Biochim Biophys Acta 2009, 1792(3):163-172.
9. Skibola C.F., Bracci P.M., Nieters A., Brooks-Wilson A., de Sanjosé S., Hughes A.M., et al. Tumor necrosis factor (TNF) and lymphotoxin-alpha (LTA) polymorphisms and risk of non-Hodgkin lymphoma in the InterLymph Consortium. Am J Epidemiol 2010, 171(3):267-276.
10. Seidemann K., Zimmermann M., Book M., Meyer U., Burkhardt B., Welte K., et al. Tumor necrosis factor and lymphotoxin alpha genetic polymorphisms and outcome in pediatric patients with non-Hodgkin's lymphoma. J Clin Oncol 2005, 23(33):8414-8421.
11. Armitage J.O. Staging non-Hodgkin lymphoma. CA Cancer J Clin 2005, 55:368-376.
12. Jrad B.B, Chatti A., Laatiri A., Ben Ahmed S., Romdhane A., Ajimi S., et al. Tumor necrosis factor promoter gene polymorphism associated with increased susceptibility to non-Hodgkin's lymphomas. Eur J Haematol 2006, 78:117-122.
13. Warzocha K., Coiffier B., Salles G., Ribeiro P., Bienvenu J., Roy P., et al. Genetic polymorphisms in the tumor necrosis factor locus influence non-Hodgkin's lymphoma outcome. Blood 1998, 91:3574-3581.
14. Cerhan J.R., Wang S.S., Maurer M.J., Ansell S.M., Geyer S.M., Cozen W., et al. Prognostic significance of host immune gene polymorphisms in follicular lymphoma survival. Blood 2007, 109(12):5439-5446.
15. Spink C.F., Keen L.J., Mensah F.K., Law G.R., Bidwell J.L., Morgan G.J. Association between non-Hodgkin lymphoma and haplotypes in the TNF region. Br J Haematol 2006, 133(3):293-300.
16. Wang S.S., Slager S.L., Brennan P., Holly E.A., De Sanjose S., Bernstein L., et al. Family history of hematopoietic malignancies and risk of non-Hodgkin lymphoma (NHL): a pooled analysis of 10211 cases and 11905 controls from the International Lymphoma Epidemiology Consortium (InterLymph). Blood 2007, 109(8):3479-3488.
17. Wang S.S., Davis S., Cerhan J.R., Hartge P., Severson R.K., Cozen W., et al. Polymorphisms in oxidative stress genes and risk for non-Hodgkin lymphoma. Carcinogenesis 2006, 27(9):1828-1834.
18. Cerhan J.R., Liu-Mares W., Fredericksen Z.S., Novak A.J., Cunningham J.M., Kay N.E., et al. Genetic variation in tumor necrosis factor and the nuclear factor-kb canonical pathway and risk of non-Hodgkin's lymphoma. Cancer Epidemiol Biomarkers Prev 2008, 17(11):3161-3169.
19. Jevtovic-Steimenov T., Kocic G., Pavlovic D., Macukanovic-Golubovic L., Marjanovic G., Djordjevic V., et al. Polymorphisms of tumor-necrosis factor-alpha-308 and lymphotoxin-alpha+250: possible modulation of susceptibility to apoptosis in chronic lymphocytic leukemia and non-Hodgkin lymphoma mononuclear cells. Leuk Lymphoma 2008, 49(11):2163-2169.